Latest filing published 28 Jun 2024 for ExpreS2ion Biotech Holding AB (EXPRS2), €293.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Martin Roland Jensen: trading record in brief
This profile gathers the share dealings of Martin Roland Jensen across 2 companies, led by ExpreS2ion Biotech Holding AB (EXPRS2) and ExpreS2ion Biotech Holding AB. Over a trading history stretching from 24 August 2017 to 27 June 2024, the count stands at 29 filings.
On the open market, the record shows 3 purchases worth €62k and 20 sales worth €589k. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2024 to date brings no purchases and 2 sales.
A typical purchase (the median) is worth €7,273. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 28 June 2024 with an open-market sale (€293) in ExpreS2ion Biotech Holding AB (EXPRS2). The most recent open-market purchase was published on 13 October 2020, 2,217 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 4 days. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin Roland Jensen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500,000 shares@ SEK 0.00220.1% of flowTeckningsrätt/UniträttISIN SE0022088183FI:csv-2f0150f9283694679028
- 105,000 shares@ SEK 1.001.8% of flowBTU (betald tecknad unit)ISIN SE0022088191FI:csv-c0be3d9304fb6204e601
- 1,000,000 sharesTeckningsrätt/UniträttISIN SE0022088183FI:csv-5e3d34e84c6386693bc0
- 25,000 shares@ SEK 3.251.4% of flowAktieISIN SE0008348262FI:csv-23d3ee8e4f886385586f
- 54,436 shares@ SEK 0.0070.0% of flowTeckningsrätt/UniträttISIN SE0019925009FI:csv-f6782c7d4796ff9895da
- 20,413 shares@ SEK 0.140.1% of flowTeckningsrätt/UniträttISIN SE0017780679FI:csv-30ae3f7f4d31604700ec
- 15,000 shares@ SEK 50.0214.0% of flowAktieISIN SE0008348262FI:csv-b396b673b56987f110b0
- 15,000 shares@ SEK 52.0014.6% of flowAktieISIN SE0008348262FI:csv-8afff3a949b2d8b431d2
- 498,069 shares0AktieISIN SE0008348262FI:csv-b730dba01af0bbd93a76
- 15,000 shares@ SEK 38.5010.9% of flowAktieISIN SE0008348262FI:csv-7a2e1bdf6a5498f8c457
- 15,000 shares@ SEK 40.0011.3% of flowAktieISIN SE0008348262FI:csv-5500cba19c01fce3c216
- 15,000 shares@ SEK 42.00100.0% of flowAktieISIN SE0008348262FI:A001R218-1
- 15,000 shares@ SEK 30.008.5% of flowAktieISIN SE0008348262FI:csv-e7c9496c36649ed8ce4c
- 15,000 shares@ SEK 32.509.2% of flowAktieISIN SE0008348262FI:csv-9bb940a70332f637f033
- 15,000 shares@ SEK 40.0011.3% of flowAktieISIN SE0008348262FI:csv-82baf5bf48225e88f6d7
- 7,000 shares@ SEK 40.005.3% of flowAktieISIN SE0008348262FI:csv-5b3115e317db753fa461
- 13,000 shares@ SEK 40.9210.0% of flowAktieISIN SE0008348262FI:csv-d5e473e2ebe5a7bbb385
- AvyttringISIN EXPRES2 URFI:csv-456ce3eca134c14ba9db
- AvyttringISIN EXPRES2 URFI:csv-df22cfab9d74a5e4990e
- Gåva lämnadISIN EXPRES2 URFI:csv-2565376b4fa667242879
- 1,744,370 shares0TeckningsrättISIN SE0014957957FI:csv-6cfa8956d49c26aa6250
- 46,291 shares@ SEK 12.0038.0% of flowAktieISIN SE0008348262FI:csv-31cfde5ded880869b05aCanonical exit: 7 Jan 2021 (T+90)
- 69,436 shares@ SEK 0.7283.5% of flowTeckningsrättISIN SE0014957957FI:csv-91ad355403621aebca21
- 140,000 shares@ SEK 0.7287.0% of flowTeckningsrättISIN SE0014957957FI:csv-9ec572b2f54766ba731c
- 2,327 shares@ SEK 8.001.3% of flowISIN SE0008348262FI:csv-84c9c49610d6c4001837Canonical exit: 28 May 2018 (T+90)
25 of 29 declarations